Acute lymphoblastic leukaemia: open trials in Finland

13 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-10-26
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
HUS-Yhtymae (HUS Helsinki University Hospital), Helsinki
Registry updated 2026-10-20
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
HUS, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · TAYS Sydaenkeskus Oy, Tampere · University Of Turku, Turku
Registry updated 2026-10-19
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
HUS-Yhtymae, Helsinki
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki, Helsinki
Registry updated 2026-09-04
NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Research · Mats Heyman
Helsinki University Hospital, Dept of Haematology, Helsinki · Helsinki University Hospital, Dept of Paediatrics, Helsinki · Kuopio University Hospital, Dept of Paediatrics, Kuopio · Kuopio University Hospital, Dept of Haematology, Kuopio · Oulu University Hospital, Dept of Haematology, Dept of Medicine, Oulu · Oulu University Hospital, Dept of Paediatrics, Oulu · Tampere University Hospital, Dept of Paediatrics, Tampere · Tampere University Hospital, Dept of Haematology, Tampere · Turku University Hospital, Dept of Paediatrics, Turku · Turku University Hospital, Clinical Haematology and Stem Cell Transplantation Unit, Turku
Registry updated 2026-08-13
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-08-12
2023-504694-20-00
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
HUS Helsinki University Hospital, Helsinki
Registry updated 2026-06-04
2025-520982-39-00
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca
New Children’s Hospital, Helskinki University Hospital, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku
Registry updated 2026-05-08
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Pohjois-Pohjanmaan hyvinvointialue, Oulu · Pirkanmaan hyvinvointialue, Tampere · Varsinais-Suomen hyvinvointialue, Turku
Registry updated 2026-03-17
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
HUS-Yhtymae, Helsinki
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
HUS Helsinki University Hospital, Helsinki
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
HUS-Yhtymae, Helsinki
Registry updated 2025-09-16

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error